96 related articles for article (PubMed ID: 16968989)
1. Gene-based therapy for hypertension--do preclinical data suggest a promising future?
Puddu GM; Cravero E; Ferrari E; Muscari A; Puddu P
Cardiology; 2007; 108(1):40-7. PubMed ID: 16968989
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides strategy in the treatment of hypertension.
Kagiyama S; Kagiyama T; Phillips MI
Curr Opin Mol Ther; 2001 Jun; 3(3):258-64. PubMed ID: 11497350
[TBL] [Abstract][Full Text] [Related]
3. Antisense inhibition of the renin-angiotensin system in brain and peripheral organs.
Mohuczy D; Phillips MI
Methods; 2000 Nov; 22(3):197-209. PubMed ID: 11071815
[TBL] [Abstract][Full Text] [Related]
4. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
5. Antisense therapeutics for hypertension: targeting the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 106():51-68. PubMed ID: 15375312
[No Abstract] [Full Text] [Related]
6. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
7. Antisense approaches to cancer gene therapy.
Mercola D; Cohen JS
Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for hypertension: antisense inhibition with adeno-associated viral vector delivery targeting angiotensin II type 1-receptor messenger ribonucleic acid.
Phillips MI
Am J Cardiol; 1998 Nov; 82(10A):60S-62S. PubMed ID: 9860363
[No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension.
Katovich MJ; Grobe JL; Huentelman M; Raizada MK
Exp Physiol; 2005 May; 90(3):299-305. PubMed ID: 15640278
[TBL] [Abstract][Full Text] [Related]
10. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
Zhang YC; Taylor MM; Samson WK; Phillips MI
Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
[No Abstract] [Full Text] [Related]
11. Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.
Reaves PY; Wang HW; Katovich MJ; Gelband CH; Raizada MK
Methods; 2000 Nov; 22(3):211-8. PubMed ID: 11071816
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for hypertension: antisense inhibition of the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 108():363-79. PubMed ID: 16028695
[TBL] [Abstract][Full Text] [Related]
13. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
14. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
[TBL] [Abstract][Full Text] [Related]
15. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
Gyurko R; Tran D; Phillips MI
Am J Hypertens; 1997 May; 10(5 Pt 2):56S-62S. PubMed ID: 9160782
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy].
Rodríguez-Fragoso L
Rev Invest Clin; 1997; 49(5):397-409. PubMed ID: 9527700
[TBL] [Abstract][Full Text] [Related]
17. The future of hypertension therapy: sense, antisense, or nonsense?
Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK
Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies.
Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571
[TBL] [Abstract][Full Text] [Related]
20. [Development of in vivo gene transfer methods towards future gene therapy].
Kaneda Y; Morishita R
Rinsho Byori; 1997 Feb; 45(2):99-105. PubMed ID: 9121006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
